Lawsuits for Patients with Gadolinium Deposition Disease

Last Updated on December 17, 2018

Investigation Complete

Attorneys working with ClassAction.org have finished their investigation into this matter.

Check back for any potential updates. The information on this page is for reference only.

Free Consumer Tools: 

View List of Lawsuits
→
Comments |

At A Glance

This Alert Affects:
Anyone who has been diagnosed with or developed symptoms of gadolinium deposition disease (GDD) following multiple MRIs.
What’s Gadolinium Deposition Disease?
GDD refers to the group of persistent symptoms that develop in MRI patients with normal kidney function within two months of being injected with a gadolinium-based contrast agent. These symptoms include “brain fog;” persistent headaches; thickened tendon and ligaments; and tingling, burning and numbness.
What’s Going On?
Patients are suing the manufacturers of gadolinium-based contrast agents claiming that the dyes made them sick and that they’re owed money for their suffering and medical costs.
How Can a Lawsuit Help?
A successful case could provide patients with compensation for their medical expenses, physical and mental suffering, and wages lost from being unable to work.

Reports have surfaced that certain types of MRI contrast agents can cause serious cognitive and nervous system problems – even in patients with normal kidney function. Doctors have coined these issues “gadolinium deposition disease,” and now lawsuits are being filed claiming the makers of gadolinium contrast dyes didn’t do enough to warn patients and the medical community about this risk.

If you would like to speak to an attorney about your rights, fill out the form on this page. Otherwise, read on for more.

What Is Gadolinium Deposition Disease?

Gadolinium deposition disease (GDD) is a new medical term that refers to a set of persistent symptoms that develop in patients with normal and near-normal kidney function following the injection of a gadolinium-based MRI contrast agent.

Symptoms of GDD include, but are not limited to, the following:

  • Persistent headache
  • Bone and joint pain
  • Cognitive impairment, including “brain fog”
  • Painful and/or thickened tendons and ligaments
  • Numbness, tingling, “cutting,” and/or burning sensation in the arms, legs and torso
  • Tightness in hands and/or feet

These symptoms can develop within hours or up to two months following an MRI. Patients most at risk for GDD include pregnant women, children, patients with inflammatory conditions, and those who received four or more contrast MRIs.

Why Are Lawsuits Being Filed – and Against Whom?

Lawsuits are being filed against the pharmaceutical companies that manufactured the gadolinium-based contrast dyes. It’s being alleged that the companies knew or should have known about the risk of serious injury developing in patients with normal kidney function. The lawsuits further claim the drug companies didn’t do enough to warn patients and doctors – and that a safer, alternative type of contrast agent was available.

In December 2017, the FDA announced that it was requiring a new warning for all gadolinium-based contrast agents. The warning advises that gadolinium can remain in the body – including in the brain – for months to years after the contrast agent is injected. The agency is also requiring makers of the gadolinium-based contrast dyes to conduct further studies on the safety of these injections.   

What Could I Get from a Lawsuit?

A lawsuit could help patients diagnosed with gadolinium deposition disease collect money for:

  • Medical bills
  • Wages lost from being unable to work
  • Physical and mental suffering

Is This a Class Action?

No. These lawsuits are being filed on an individual basis; there is no class action lawsuit you can join. If you want to sue for your injuries, you will need to hire your own attorney and file your own case.

Before commenting, please review our comment policy.